Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Cheryl Neslusan"'
Autor:
James B. Wetmore, Suying Li, Thanh G. N. Ton, Yi Peng, Michael K. Hansen, Cheryl Neslusan, Ralph Riley, Jiannong Liu, David T. Gilbertson
Publikováno v:
BMC Endocrine Disorders, Vol 19, Iss 1, Pp 1-11 (2019)
Abstract Background Diabetes-related kidney disease is associated with end-stage renal disease and mortality, but opportunities remain to quantify its association with cardiovascular and non-cardiovascular morbidity outcomes. Methods We used the Truv
Externí odkaz:
https://doaj.org/article/d3a8394ab9bc42d587a30f10203682cc
Autor:
Julia Thornton Snider, Jeffrey Sullivan, Emma van Eijndhoven, Michael K Hansen, Nobel Bellosillo, Cheryl Neslusan, Ellen O'Brien, Ralph Riley, Seth Seabury, Bertram L Kasiske
Publikováno v:
PLoS ONE, Vol 14, Iss 5, p e0217487 (2019)
ObjectivesDiabetic kidney disease (DKD) is a frequent complication of diabetes with potentially devastating consequences that may be prevented or delayed. This study aimed to estimate the health and economic benefit of earlier diagnosis and treatment
Externí odkaz:
https://doaj.org/article/5899e5b6e8d546f490f417754fef639b
Autor:
Dominic Pilon, Cheryl Neslusan, Maryia Zhdanava, Laura Morrison, Tom Cornwall, Patrick Lefebvre, Abigail I. Nash, Maude Vermette-Laforme, Kruti Joshi, Jennifer Voelker
Publikováno v:
Pharmacoeconomics
Background and Objective Suicidal ideation or behavior are core symptoms of major depressive disorder (MDD). This study aimed to understand heterogeneity among patients with MDD and acute suicidal ideation or behavior. Methods Adults with a diagnosis
Publikováno v:
Current medical research and opinion. 38(9)
Although a high incidence of major depressive disorder (MDD) and an increased risk of suicide are observed among the veteran population, there are yet limited real-world data characterizing patients with MDD with acute suicidal ideation/behavior (MDS
Publikováno v:
PharmacoEconomics. 39:447-461
Widely used risk equations for cardiovascular outcomes for individuals with type 2 diabetes mellitus (T2DM) have been incapable of predicting cardioprotective effects observed in recent cardiovascular outcomes trials (CVOTs) involving individuals wit
Autor:
Dominic Pilon, Cheryl Neslusan, Maryia Zhdanava, John J. Sheehan, Kruti Joshi, Laura Morrison, Carmine Rossi, Patrick Lefebvre, Paul E. Greenberg
Publikováno v:
The Journal of clinical psychiatry. 83(3)
Publikováno v:
Diabetes Therapy
Introduction The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) study showed that compared with placebo, canagliflozin 100 mg significantly reduced the risk of major cardiovascular events and
Autor:
Jennifer Voelker, Samuel T. Wilkinson, Eva G. Katz, Abigail I. Nash, Ella Daly, Ahan Ali, Adrienne Lovink, John Stahl, Arkit Desai, Harsh Kuvadia, Cheryl Neslusan, John J. Sheehan
Publikováno v:
The Journal of nervous and mental disease. 210(5)
To ascertain the relative importance of attributes considered when deciding to discharge patients hospitalized with major depressive disorder (MDD) and active suicidal ideation with intent, a choice-based conjoint analysis was conducted via online su
Publikováno v:
Diabetes Therapy
Introduction Cardiovascular disease is a leading cause of mortality in people with type 2 diabetes mellitus (T2DM). Beginning in 2015, long-term cardiovascular outcomes trials (CVOTs) have reported cardioprotective benefits for two classes of diabete
Autor:
Silas Martin, Ira Klein, Cheryl Neslusan, Duncan O'Brien, Michael Willis, Pierre Johansen, Christian Asseburg
Publikováno v:
Journal of Clinical Pathways. 5:26-29